Vicky Kritikos

Mepolizumab effectiveness and identification of super-responders in severe asthma

David Langton, Constance H. Katelaris, Sean Stevens et al. · European Respiratory Journal · 2020 · 193 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +16

Treatable traits can be identified in a severe asthma registry and predict future exacerbations

Vanessa M. McDonald, Sarah A. Hiles, Krystelle Godbout et al. · Respirology · 2018 · 185 citations · Full text

Medicine, Internal Medicine, Allergy +13

Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

Peter G. Gibson, Helen K. Reddel, Vanessa M. McDonald et al. · Internal Medicine Journal · 2016 · 83 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Working while unwell: Workplace impairment in people with severe asthma

Sarah A. Hiles, Vanessa M. McDonald, Matthew Peters et al. · Clinical & Experimental Allergy · 2018 · 81 citations · Full text

Public Health, Health Sciences, Employee Health Surveillance +14

Understanding reliever overuse in patients purchasing over-the-counter short-acting beta ₂ agonists: an Australian community pharmacy-based survey

Elizabeth Azzi, Vicky Kritikos, Matthew Peters et al. · BMJ Open · 2019 · 76 citations · Full text

Pharmacy, Community Pharmacy, Pharmacy Practice +17